A case of advanced hepatocellular carcinoma with portal vein tumor invasion controlled by percutaneous ethanol injection therapy
- Authors
- Yoon, I.; Yim, H.J.; Kim, J.N.; Park, S.M.; Kim, J.H.; Lee, S.H.; Chung, H.H.; Lee, H.S.; Lee, S.W.; Choi, J.H.
- Issue Date
- 2009
- Keywords
- 간세포암종; 간문맥 종양혈전; 경동맥화학색전술; 경피적 에탄올주입술; Carcinoma; Hepatocellular; Portal vein tumor thrombosis; Transarterial chemoembolization; Percutaneous ethanol injection therapy
- Citation
- The Korean journal of hepatology, v.15, no.1, pp.90 - 95
- Indexed
- SCOPUS
KCI
- Journal Title
- The Korean journal of hepatology
- Volume
- 15
- Number
- 1
- Start Page
- 90
- End Page
- 95
- URI
- https://scholar.korea.ac.kr/handle/2021.sw.korea/121847
- DOI
- 10.3350/kjhep.2009.15.1.90
- ISSN
- 1738-222X
- Abstract
- Portal vein invasion is a grave prognostic indicator in the setting of hepatocellular carcinoma (HCC). There is currently no effective method for preventing the invasion of HCC into the main portal vein. We report here a case of advanced HCC with portal vein tumor thrombosis that was effectively treated with percutaneous ethanol injection (PEI), having previously enabled subsequent successive transarterial chemoembolization (TACE). A 60-year-old male patient was diagnosed with a huge HCC, based on computed tomography and angiographic findings. Despite two sessions of TACE, the tumor invaded the right portal vein. PEI was performed on the malignant portal vein thrombosis, and three sessions thereof reduced the extent of tumor thrombi in the portal vein. Successive TACEs were performed to treat the HCC in the hepatic parenchyma. The patient was still living 19 months after the first PEI with no evidence of tumor recurrence, and his liver function remained well preserved.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medical Science > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.